Literature DB >> 2538443

Inducible overexpression, purification, and active site mapping of DNA topoisomerase II from the yeast Saccharomyces cerevisiae.

S T Worland1, J C Wang.   

Abstract

Overexpression of yeast DNA topoisomerase II was achieved by placing the coding sequences of the gene TOP2 downstream of an inducible promoter PGAL1 on a multicopy plasmid. By using a simple purification procedure, milligram amounts of the enzyme of a high specific activity can be obtained from a few liters of culture. In the presence of a drug VM-26 (teniposide), more than 90% of the enzyme molecules become covalently bound to DNA upon addition of the protein denaturant sodium dodecyl sulfate. The formation of the covalent complex was used to map the tyrosine residue that becomes covalently linked to DNA when the enzyme transiently breaks DNA. After exhaustive digestion of the DNA-protein complex with trypsin, a DNA-linked peptide was purified and sequenced directly to identify Tyr-783 as the active site residue.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2538443

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  89 in total

1.  Novel display of knotted DNA molecules by two-dimensional gel electrophoresis.

Authors:  S Trigueros; J Arsuaga; M E Vazquez; D W Sumners; J Roca
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

2.  Knotting probability of DNA molecules confined in restricted volumes: DNA knotting in phage capsids.

Authors:  Javier Arsuaga; Mariel Vázquez; Sonia Trigueros; De Witt Sumners; Joaquim Roca
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

3.  Amsacrine as a topoisomerase II poison: importance of drug-DNA interactions.

Authors:  Adam C Ketron; William A Denny; David E Graves; Neil Osheroff
Journal:  Biochemistry       Date:  2012-02-10       Impact factor: 3.162

4.  The geometry of DNA supercoils modulates topoisomerase-mediated DNA cleavage and enzyme response to anticancer drugs.

Authors:  A Kathleen McClendon; Neil Osheroff
Journal:  Biochemistry       Date:  2006-03-07       Impact factor: 3.162

5.  Topoisomerase II, not topoisomerase I, is the proficient relaxase of nucleosomal DNA.

Authors:  Javier Salceda; Xavier Fernández; Joaquim Roca
Journal:  EMBO J       Date:  2006-05-18       Impact factor: 11.598

6.  Proteolysis patterns of epitopically labeled yeast DNA topoisomerase II suggest an allosteric transition in the enzyme induced by ATP binding.

Authors:  J E Lindsley; J C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

7.  Overcoming target-mediated quinolone resistance in topoisomerase IV by introducing metal-ion-independent drug-enzyme interactions.

Authors:  Katie J Aldred; Heidi A Schwanz; Gangqin Li; Sylvia A McPherson; Charles L Turnbough; Robert J Kerns; Neil Osheroff
Journal:  ACS Chem Biol       Date:  2013-09-30       Impact factor: 5.100

8.  Mapping the active-site tyrosine of vaccinia virus DNA topoisomerase I.

Authors:  S Shuman; E M Kane; S G Morham
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

9.  Oxidative metabolites of curcumin poison human type II topoisomerases.

Authors:  Adam C Ketron; Odaine N Gordon; Claus Schneider; Neil Osheroff
Journal:  Biochemistry       Date:  2012-12-26       Impact factor: 3.162

10.  cin-4, a gene with homology to topoisomerase II, is required for centromere resolution by cohesin removal from sister kinetochores during mitosis.

Authors:  Gerald Stanvitch; Landon L Moore
Journal:  Genetics       Date:  2008-01       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.